150 KRW
−19.43 B KRW
135.95 B KRW
25.92 M
About HLB PHARMACEUTICAL
Sector
CEO
Jae-Hyeong Park
Headquarters
Namyangju
Website
Founded
1998
ISIN
KR7047920004
FIGI
BBG00BGK1JG3
HLB Pharmaceutical Co., Ltd. engages in the manufacturing and selling prescription drugs and consignment business. It operates through the following business divisions: Medicines, Non-Medicinal Products, and Health Functional Food. The company was founded on April 23, 1998 and is headquartered in Namyangju-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 047920 is 25,700 KRW — it has decreased by −2.10% in the past 24 hours. Watch HLB PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HLB PHARMACEUTICAL stocks are traded under the ticker 047920.
047920 stock hasn't changed in a week, the month change is a 18.71% rise, over the last year HLB PHARMACEUTICAL has showed a 87.59% increase.
047920 reached its all-time high on Mar 21, 2024 with the price of 42,050 KRW, and its all-time low was 2,650 KRW and was reached on Mar 23, 2020. View more price dynamics on 047920 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
047920 stock is 8.92% volatile and has beta coefficient of 2.15. Track HLB PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is HLB PHARMACEUTICAL there?
Today HLB PHARMACEUTICAL has the market capitalization of 817.63 B, it has decreased by −1.98% over the last week.
Yes, you can track HLB PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
047920 net income for the last quarter is 948.06 M KRW, while the quarter before that showed 496.29 M KRW of net income which accounts for 91.03% change. Track more HLB PHARMACEUTICAL financial stats to get the full picture.
No, 047920 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 26, 2025, the company has 222.00 employees. See our rating of the largest employees — is HLB PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLB PHARMACEUTICAL EBITDA is 3.55 B KRW, and current EBITDA margin is −11.24%. See more stats in HLB PHARMACEUTICAL financial statements.
Like other stocks, 047920 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLB PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HLB PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HLB PHARMACEUTICAL stock shows the strong buy signal. See more of HLB PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.